DecNef for AVH in Schizophrenia
Part of paid clinical trials in New York, New York.
- Sponsor
- New York State Psychiatric Institute
- Study ID
- NCT07779226
- Phase
- PHASE1/PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Schizoaffecitve Disorder
- Schizophrenia Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- Decoded Neurofeedback — DEVICEIn this study participants will be randomly assigned to either active or control decoded neurofeedback.
Study Details
The purpose of this study is to learn whether a research neurofeedback training approach done during MRI scans may help reduce hallucinations such as the experience of hearing voices persistent despite treatment.
Key Dates
- First listed
- Aug 21, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Jan 1, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 51 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Active Decoded NeurofeedbackDecoded Neurofeedback is a real-time fMRI technique designed to modulate within-region activation patterns via pattern-based neurofeedback, which is thought to induce selective plasticity. In this study, we are targeting schizophrenia symptoms.
- Active Comparator: ControlThe active comparator is similar to the experimental condition but does not target schizophrenia symptoms.
Primary Outcome Measure
Target Engagement [ Time Frame: During MRI sessions (from randomization through final MRI scan). ]
Central Contacts
- Katelyn Mills646-774-8496
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University | New York | New York | 10027 | Tessel Veldhoen |
Find similar trials in New York, NY
By research site
Related Studies
- A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaPHASE1/PHASE2 · Recruiting · New York State Psychiatric Institute · New York, New York
- A Virtual Reality Mindfulness Application for Aggression in SchizophreniaRecruiting · Manhattan Psychiatric Center · New York, New York
- MicroRNAs as Biomarkers in First Episode SchizophreniaRecruiting · Northwell Health · Glen Oaks, New York
- Incentives and Long-Acting Injectable Adherence After Involuntary HospitalizationEnrolling By Invitation · Stanford University · Pittsburgh, Pennsylvania